PROTAC CRABP-II Degrader-2 is primarily used in research and therapeutic development to target and degrade CRABP-II (cellular retinoic acid-binding protein II). This chemical is a key tool in studying the role of CRABP-II in cellular processes, particularly in diseases like cancer where CRABP-II overexpression may play a role. By inducing the degradation of CRABP-II, it helps researchers understand its function and potential as a therapeutic target. Additionally, it is explored in drug development for conditions where modulating retinoic acid signaling pathways could be beneficial, such as in certain types of cancer or skin disorders. Its application in PROTAC (Proteolysis Targeting Chimera) technology highlights its potential in targeted protein degradation, a promising approach in precision medicine.